{"id": "1365029046141157376", "creation": 1614283260.0, "user_id": "1320835110422433794", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "quoted": "1364349320925954049", "text": "In addition to the Phase II/III trial of our #COVID19 #vaccine we will continue working on other vaccines, including SARS-CoV-2 variants, and cancer therapies. Read more about our plans in this @Endpoints interview with Clover\u2019s CEO, Joshua Liang. https://t.co/mn66SVgD3L", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}